drugset / Trial / NCT04182321

Metformin as Add-on to the Standard Therapy in Patients With Chronic Hepatitis B

NCT04182321

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of metformin as add-on to entecavir therapy in patients with chronic hepatitis B.

Timeline

Start
2020-03-13
Primary completion
2021-07-02
Completion
2021-09-13

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1000 mg Oral
Background Entecavir Small molecule 0.5 mg Oral